Related Experiment Videos
Cardiomyopathy: how far have we come in 25 years, how far yet to go?
Insights
Cardiomyopathy research has advanced, yet causes of dilated cardiomyopathy remain unclear. New methods like exercise oxygen consumption show promise for assessing treatment effectiveness in heart disease.
Area of Science:
- Cardiology
- Internal Medicine
- Heart Disease Research
Background:
- Cardiomyopathy is a significant heart disease, with classifications evolving over 25 years.
- Distinguishing myocarditis from dilated cardiomyopathy and understanding dilated cardiomyopathy causes remain challenging.
- While myocardial biopsy is useful for specific conditions, its utility in dilated cardiomyopathy is limited.
Purpose of the Study:
- To review the current understanding and evolving concepts of various cardiomyopathies.
- To highlight diagnostic and therapeutic challenges in managing heart muscle diseases.
- To discuss the role of emerging assessment methods and treatments.
Main Methods:
- Review of clinical investigations and proposed functional classifications.
- Analysis of diagnostic limitations, including myocardial biopsy in dilated cardiomyopathy.
- Evaluation of exercise capacity and oxygen consumption measurements.
- Discussion of treatment modalities including pharmacotherapy and surgery.
Main Results:
- Exercise capacity is influenced by peripheral factors, not solely ventricular function.
- Measurements of oxygen consumption during exercise may aid in assessing dilated cardiomyopathy treatment.
- True restrictive cardiomyopathy is rare, but restrictive filling is common in cardiac disorders.
- Arrhythmia is an increasingly recognized cause of sudden cardiac death.
- Amiodarone shows utility in treating dilated and hypertrophic cardiomyopathy.
Conclusions:
- Despite advances, the etiology of dilated cardiomyopathy, particularly viral and alcohol-related factors, requires further investigation.
- Exercise oxygen consumption offers a promising avenue for treatment assessment in dilated cardiomyopathy.
- Hypertrophic cardiomyopathy concepts continue to evolve, with ongoing research into treatments like calcium channel blockers.
- Amiodarone and surgical interventions play significant roles in managing cardiomyopathies, though mechanisms require further study.
Abstract:
Twenty-five years ago clinical investigators began to appreciate that cardiomyopathy is an important and reasonably common form of heart disease. Since then, several functional classifications have been proposed, the specific myocardial diseases have been classified and chronic ischemic ventricular failure has been described. The boundary separating myocarditis from dilated cardiomyopathy remains hazy and, despite intensive research, the causes of dilated cardiomyopathy remain obscure. In particular, we still do not understand the role that may be played by viral infection and alcohol. Myocardial biopsy has proved useful in patients with specific myocardial disorders, heart transplant recipients and patients receiving Adriamycin, but is disappointing in patients with dilated cardiomyopathy. It has become increasingly evident that exercise capacity does not correlate with ventricular function, being highly dependent on peripheral factors. Measurements of oxygen consumption during exercise promise to be useful in assessing treatment of dilated cardiomyopathy. True restrictive cardiomyopathy is uncommon, and the term should be reserved for cardiomyopathies that meet strict criteria. A restrictive component to filling is common to many cardiac disorders, including some cases of cardiac amyloidosis. The concept of hypertrophic cardiomyopathy has evolved rapidly over the past 25 years, and continues to evolve. The importance of arrhythmia as a cause of sudden death is becoming increasingly clear. The place of calcium channel blocking agents in the treatment of hypertrophic cardiomyopathy will probably emerge soon. Amiodarone is finding an increasing role in the treatment of dilated and hypertrophic cardiomyopathy. Surgical treatment is still required for some patients despite unanswered questions on how it works.